MedTrace Logo

Skeletal Metastasis Registry

NCT05058014 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-10-29

No results posted yet for this study

Summary

This is a prospective, observational study designed to contribute data from patients with symptomatic metastatic bone disease treated at Sibley Memorial Hospital and Johns Hopkins Medicine to an international registry hosted by the Swedish Regional Cancer Centrum in Stockholm, Sweden. This protocol supports a worldwide effort to collect and store information from patients treated for symptomatic bone metastases within the International Skeletal Metastasis Registry (ISMR)

Conditions

  • Metastatic Bone Tumor

Sponsors & Collaborators

  • Murtha Cancer Center

    collaborator UNKNOWN

  • Defense Health Programs with the U.S. Army Medical Research and Materiel Command

    collaborator UNKNOWN

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Adam Levin, MD · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-16
Primary Completion
2023-12-06
Completion
2023-12-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05058014 on ClinicalTrials.gov